The U.S. Food and Drug Administration has approved Jobevne (bevacizumab-nwgd), a biosimilar to Avastin (bevacizumab) for ...

23-year-old ovarian cancer survivor and 2025 Witchery White Shirt Ambassador Jemima Leydon shares her story with this lethal ...

Ovarian cancer is one of those. Ovarian cancer starts in the ovaries, which are two small glands located on either side of the uterus that produce eggs and important hormones like estrogen and ...

Dr Emma Bolderson, from QUT's School of Biomedical Sciences, has received a $460,552 grant from the Ovarian Cancer Research ...

Discover the Witchery White Shirt Campaign 2025 in collaboration with Viktoria & Woods founder, Margie Woods, for ovarian ...

Witchery has released it's white shirt campaign, with 100% of proceeds going towards research for an early detection test for ovarian cancer.

Drs Ursula A. Matulonis and Gini F. Fleming discuss the state of endometrial cancer, the role of immunotherapy, and priorities for research in this field.

Biocon Biologics, a subsidiary of India-based Biocon Ltd, said on Thursday that U.S. FDA has approved Jobevne, a biosimilar ...

Menstrual disorders, causes, and management explained by obstetric-gynaecologists at Naruvi Hospitals, Vellore for women's ...

Distinguished, highly accomplished clinician with stellar track record of successfully leading numerous registrational trials ...

Four leading companies CTMC, Iovance Therapeutics, KSQ, and TILT Biotherapeutics prognosticate coming successes of new technology approaches to better tumor-infiltrating lymphocyte activities.

North America Cancer Diagnostics Market Size Set Expands at Significant CAGR of 6.11% During 2024-2030 to Reach USD 23.48 Billion by 2030 Request To Download Free Sample of This Strategic Report @ ...